About us
Contact us
Switchboard: +358 29 522 3341
fax +358 29 522 3002
Calls received by Fimea's telephone exchange may be recorded in order to improve our customer service. Only your discussion with the exchange operator will be recorded. The recordings will not be used for any other purposes.
Registrar's office: registry@fimea.fi
tel. +358 29 522 3602
fax +358 29 522 3002
E-mail addresses follow the form firstname.lastname@fimea.fi
The contact information of Fimea personnel is available through Contact Information Directory. You can use the following as search words: the name of an individual (forename and/or sur-name) or agency, city, email address, organisation/unit, title, or address.
Postal address:
P.O. Box 55, FI-00034 FIMEA, FINLAND
Visiting addresses:
Microkatu 1, 70210 Kuopio
Mannerheimintie 103b, 00280 Helsinki
Mannerheimintie 166, 00300 Helsinki (Laboratory)
Itsenäisyydenaukio 2, 20800 Turku
Biokatu 10, 33520 Tampere
Delivery address for courier service:
Nauvontie 4, 00280 Helsinki, Finland
***
If you suspect that you have experienced an adverse drug reaction, tell your attending physician or dentist about it.
Urgent matters relating to pharmaceutical service for healthcare professionals:
Product defects (24hrs):
qdefect@fimea.fi
tel. +358 29 522 3202
Special permissions:
fax +358 29 522 3006
Pharmacovigilance outside office hours:
tel. +358 29 522 3980
Communications
communications@fimea.fi
Communications Director Minna Takaloeskola
tel. +358 29 522 3115
Communications Manager Katja Lindgren-Äimänen
tel. +358 29 522 3118
Web Specialist Tuukka Tenhunen
tel. +358 29 522 3117
Communications Specialist Riitta Vuorela
tel. +358 29 522 3119
Communications Specialist Petra Nylund
tel. +358 29 522 3122
Marketing authorisation applications
Applications for marketing authorisations must be submitted using the common EU application form regardless of the procedure applied.
Instructions for electronic submission of marketing authorisations
Management:
Director General Eija Pelkonen
tel. +358 29 522 3100
Supervision and licences
Director Eeva Leinonen
tel. +358 29 522 3200
Head of Unit Pirjo Rosenberg, Inpectorate
tel + 358 29 522 3220
Head of Unit Anne Junttonen, Supervision Control and Development Unit
tfn + 358 29 522 3219
Head of Unit Timo Mauriala, Product Quality Control Unit
tel. +358 29 522 3214
Assessment of medicinal products
Director Esa Heinonen
tel- + 358 29 522 3300
Head of Unit Marjo-Riitta Helle, Pharmaco-Biological Unit
tel. +358 29 522 3320
Head of Unit Jukka Sallinen, Clinico-Pharmacological Unit
tel. +358 29 522 3410
Head of Unit Leena Pietilä, Regulatory Processes Unit
tel. +358 29 522 3360
Head of Unit Irmeli Happonen, Veterinary Medicines Unit
tel. +358 29 522 3330
Head of Unit Liisa Näveri, Pharmacovigilance Unit
tel. +358 29 522 3340
Assessment of pharmacotherapies
Director Pertti Happonen
tel.+358 29 522 3500
Administration and support services
Director Sari Kujala
tel. + 358 29 522 3610
Leading Legal Counsel Tuula Sandholm
tel. +358 29 522 3620
Finance Director Esko Kiiski
tel. +358 29 522 3630
ICT-Manager Jaakko Hartikka
tel. +358 29 522 3619
HR chef Johanna Ollila
tel. +358 29 522 3653
Pharmaceutical Bulletin Sic! Drug Information from Fimea
Editors: sic@fimea.fi
Enquiries and changes of address: tilaukset@fimea.fi
Chief Medical Editor Päivi Ruokoniemi
tel. +358 29 522 3442